Analysts expect that AbbVie Inc. (NYSE:ABBV – Get Rating) will post earnings per share (EPS) of $3.44 for the current fiscal quarter, according to Zacks. Four analysts have issued estimates for AbbVie’s earnings. The lowest EPS estimate is $3.38 and the highest is $3.52. AbbVie posted earnings per share of $3.11 during the same quarter […]
AbbVie Inc. (NYSE:ABBV – Get Rating) Vice Chairman Michael Severino sold 100,000 shares of the firm’s stock in a transaction that occurred on Monday, May 9th. The shares were sold at an average price of $150.28, for a total transaction of $15,028,000.00. Following the transaction, the insider now owns 152,103 shares in the company, valued […]
AbbVie (NYSE:ABBV – Get Rating) was downgraded by investment analysts at Daiwa Capital Markets from an “outperform” rating to a “neutral” rating in a report released on Friday, The Fly reports. ABBV has been the subject of a number of other research reports. Wells Fargo & Company lifted their price objective on shares of AbbVie […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Coca-Cola Europacific Partners PLC (NYSE:CCEP – Get Rating) – Analysts at Jefferies Financial Group lifted their FY2022 earnings per share estimates for Coca-Cola Europacific Partners in a research note issued on Thursday, April 28th. Jefferies Financial Group analyst E. Mundy now expects that the company will post earnings per share of $3.39 for the year, […]